OC.02.6 BASELINE IL-23 SERUM LEVELS PREDICT MUCOSAL HEALING IN PATIENTS WITH CROHN'S DISEASE TREATED WITH USTEKINUMAB. A PROSPECTIVE STUDY. (May 2022) - Bertani, L.